期刊文献+

重组人生存素单体分子与双体分子的原核表达研究

Prokaryotic expression of recombination human single and double molecular survivin
下载PDF
导出
摘要 目的重组并高效表达人生存素单体分子和双体分子。方法PCR扩增人生存素基因,将其单一读码框和双读码框重组到原核表达质粒载体pKpL5的表达框内,限制性内切酶分析后,于42℃诱导表达,并以SDS-PAGE和Western blotting鉴定表达结果。结果经限制性核酸内切酶分析,表达重组人生存素单体分子质粒pKpL5-sSURVIVIN和表达人生存素同源双体分子质粒pKpL5-dSURVIVIN均正确构建,可高效表达分子量约18.5KDa的人生存素单体分子与分子量约35KDa的同源双体分子,所表达的目的蛋白可被抗人生存素的多克隆抗体特异性识别。结论该研究成功高效表达人生存素单体分子与同源双体分子,为进一步研究其生物活性与免疫原性奠定了物质基础。 [Objective] To construct and express the human single and double Molecular survivin in prokaryotic cell. [Methods] Survivin cDNA amplified with PCR, and the single and double open reading frame of survivin was inserted into pKpL-5 respectively. After identified with restriction endonuclerase, the two recombinant plasmids were transformed into E. coli pep2136 and induced at 42~C for 4 hours, the expressed protein was analyied by SDS- PAGE and Western blotting. [Results] The two recombinant plasmids were constructed successfully, and the protein were expressed effectively, and the relative molecular weight were 18.5 KDa, 35 KDa respectively. Western-blot analysis demonstrated that the expressed protein exhibited specific reaction with rabbit anti-survivin pelyclone anti- body. [Conclusion] The single and double molecular survivin was expressed effectively. It lays foundation .for further study the antigenicity and the biological activity.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2008年第17期2486-2489,共4页 China Journal of Modern Medicine
基金 四川省科技厅项目(No:2002A071)
关键词 生存素 双体分子 原核表达 survivin double surviving prokaryotic expression
  • 相关文献

参考文献10

  • 1AMBROSINI G, ADIDA C, ALFIERI DC, et al. A novel anti-apoptosis gene survivin,expressed in cancer and lymphoma [J]. Nature Med, 1997, 3(8): 917-921.
  • 2ALTIERI DC. Validating survivin as a cancer therapeutic target [J]. Nat Rev Cancer, 2003, 3(2): 46-54.
  • 3KNUTSEN A, ADEll G, SUN XF. Survivin expression is an independent prognostic factor in rectal cancer patients with and without preoperative radiotherapy [J]. Int J Radiat Oncol Biol Phys, 2004, 60(5): 149-155.
  • 4JINFENG M, KIMURA W, SAKURAI F, et al. Histopathological study of intraductal papillary mucinous tumor of the pancreas: special reference to the roles of Survivin and p53 in tumorigenesis of IPMT[J]. Int J Gastrointest Cancer, 2002, 32(23): 73-81.
  • 5AMBROSINI G, ADIDA C, SIMGO G, et al. Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting[J]. Biol Chem, 1998, 273(18): 11177-11182.
  • 6VISCHIONI B, VAN DER VALK P, SPAN SW, et al. Nuclear localization of survivin is a positive prognostic factor for survival in advanced non-small-cell lung cancer[J]. Ann Oncol, 2004, 15 (11): 1654-1660.
  • 7MEGLIORINO R, SHI F, PENG X, et al. Autoimmune response to anti-apoptotie protein survivin and its association with antibodies to p53 and e-myc in cancer detection [J]. Cancer Detect Prey, 2005, 29(3): 241-248.
  • 8LEHNER R, ENOMOTO T, MCGREGOR JA, et al. Correlation of survivin mRNA detection with histologic diagonosis in normal endometrium and endometrial carcinoma[J]. Acta Obstet Gynecol Scand, 2002, 81(2): 162-167.
  • 9李容,熊冬生,邵晓枫,许元富,刘嘉,朱祯平,杨纯正.抗人VEGF受体Ⅱ基因Ⅲ区单链抗体基因的构建和表达[J].生物工程学报,2004,20(2):187-191. 被引量:3
  • 10SWENSON S, COSTA F, MINEA R, et al. Intravenous liposomal delivery of the snake venom disintegrin eontortrostatin limits breast cancer progression [J]. Mol Cancer Ther, 2004, 3 (4): 499-511.

二级参考文献2

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部